{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:11:33Z","timestamp":1779937893803,"version":"3.53.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["96006612"],"award-info":[{"award-number":["96006612"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["977467"],"award-info":[{"award-number":["977467"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.lfs.2019.117181","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:21:16Z","timestamp":1576646476000},"page":"117181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis"],"prefix":"10.1016","volume":"242","author":[{"given":"Fereshteh","family":"Asgharzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Hashemzehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Moradi-Marjaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2019.117181_bb0005","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2019.117181_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ctrv.2017.08.010","article-title":"Systemic treatment of renal cell cancer: a comprehensive review","volume":"60","author":"Sanchez-Gastaldo","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2019.117181_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2019.117181_bb0020","article-title":"Immunotherapy for advanced renal cell cancer","author":"Coppin","year":"2015","journal-title":"Cochrane Libr"},{"issue":"11","key":"10.1016\/j.lfs.2019.117181_bb0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin\u2013angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2019.117181_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1074248413501018","article-title":"Renin-angiotensin system blocking drugs","volume":"19","author":"Robles","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"9123","key":"10.1016\/j.lfs.2019.117181_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lfs.2019.117181_bb0040","first-page":"221","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review","volume":"23","author":"Mc Menamin","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.lfs.2019.117181_bb0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","article-title":"Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases","volume":"22","author":"Neo","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.lfs.2019.117181_bb0050","first-page":"1139","article-title":"Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor","volume":"2","author":"Uemura","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.lfs.2019.117181_bb0055","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/1078-0432.CCR-14-2332","article-title":"Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma","volume":"21","author":"McKay","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"9123","key":"10.1016\/j.lfs.2019.117181_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet (London, England)."},{"issue":"22","key":"10.1016\/j.lfs.2019.117181_bb0065","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1158\/0008-5472.CAN-08-0851","article-title":"Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?","volume":"68","author":"Khakoo","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.117181_bb0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.10313","article-title":"Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells","volume":"196","author":"Greco","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117181_bb0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","article-title":"Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis","volume":"294","author":"Fujita","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.lfs.2019.117181_bb0080","first-page":"4176","article-title":"Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis","volume":"62","author":"Miyajima","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.117181_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","article-title":"Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer","volume":"328","author":"Chen","year":"2013","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.lfs.2019.117181_bb0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/bjc.1998.145","article-title":"Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma","volume":"77","author":"Hii","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"suppl_4","key":"10.1016\/j.lfs.2019.117181_bb0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/annonc\/mdu325.8","article-title":"Renin angiotensin system (RAS) blockade attenuates growth and metastasis formation of renal cell carcinoma in mice","volume":"25","author":"Araujo","year":"2014","journal-title":"Ann. Oncol."},{"issue":"13","key":"10.1016\/j.lfs.2019.117181_bb0100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2011.04.019","article-title":"Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination","volume":"47","author":"Keizman","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.lfs.2019.117181_bb0105","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/1078-0432.CCR-14-2332","article-title":"Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma","volume":"21","author":"McKay","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2019.117181_bb0110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/annonc\/mdv147","article-title":"Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma","volume":"26","author":"Izzedine","year":"2015","journal-title":"Ann. Oncol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519311099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519311099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:26:59Z","timestamp":1758400019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519311099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"alternative-id":["S0024320519311099"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117181","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117181"}}